Journal
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
Volume 41, Issue 15, Pages 7277-7289Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/07391102.2022.2119278
Keywords
Methicillin-resistant Staphylococcus aureus; LLM; molecular docking; molecular dynamics simulation; MMPBSA
Categories
Ask authors/readers for more resources
In this study, virtual screening was used to identify potent antibacterial molecules that can target the LLM protein in S. aureus. Molecular docking and dynamics simulations showed that five identified molecules had higher affinities and stable interactions with the LLM protein compared to tunicamycin. These molecules can potentially be used as inhibitors of LLM in S. aureus, and even showed higher potency than previously reported molecules.
In S. aureus, lipophilic membrane (LLM) protein is a methicillin resistance factor and is an essential role in peptidoglycan metabolism. The virtual screening of antibacterial molecules against the model of LLM was performed to identify the potent antibacterial molecules. Molecular docking results of pharmacokinetic filtered molecules illustrated that five molecules had higher binding affinities than tunicamycin (TUM) and were stabled via non-covalent interactions (hydrogen bond and hydrophobic interactions) at the active site of LLM. Further, molecular dynamics results revealed that binding of identified antibacterial molecules with LLM resulted in stable LLM-inhibitor(s) complexes. Molecular Mechanics/Position-Boltzmann Surface Area (MMPBSA) analysis showed that LLM-inhibitor(s) complexes had high binding affinities in the range of -213.49 +/- 2.24 to -227.42 +/- 3.05 kJ/mol. The amino acid residues decomposition analysis confirmed that identified antibacterial molecules bound at the active site (Asn148, Leu149, Asp151, Asp208, His269, His271, and His272) of LLM. Noticeably, the current study found five antibacterial molecules (BDE 27575101, BDE 33638168, BDE 33672484, LAS 51502073, and BDE 25098678) were highly potent than TUM and even than earlier reported molecules. Therefore, here reported antibacterial molecules may be used directly or developed to inhibit LLM of S. aureus. Communicated by Ramaswamy H. Sarma
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available